Kelonia Therapeutics Funding: $50M Raised, Series A (2022)
Kelonia Therapeutics is a Biotech company based in Boston, Massachusetts. It has raised $50M in total funding. Latest round: Series A.
Kelonia Therapeutics funding overview
Kelonia Therapeutics is a Biotech company based in Boston, Massachusetts. Kelonia Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Kelonia Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Alta Partners, Horizons Ventures, Venrock. 3 distinct backers are named across the disclosed rounds.
Kelonia Therapeutics at a glance
Total raised
$50M
Latest round
Series A
Latest round date
April 2022
Industry
Biotech
Headquarters
Boston, Massachusetts
Notable investors
Alta Partners, Horizons Ventures, Venrock
Frequently asked about Kelonia Therapeutics funding
How much has Kelonia Therapeutics raised?
Kelonia Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Kelonia Therapeutics?
Alta Partners, Horizons Ventures, Venrock are named among the investors backing Kelonia Therapeutics.
What was the latest Kelonia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is Kelonia Therapeutics based?
Kelonia Therapeutics is based in Boston, Massachusetts.
What sector does Kelonia Therapeutics operate in?
Kelonia Therapeutics is tracked under Biotech from Boston, Massachusetts, with $50M in disclosed funding.
When did Kelonia Therapeutics last raise?
The last disclosed Kelonia Therapeutics round closed in April 2022 at Series A.
We update the Kelonia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
